OIM
BIOL

Oracle Investment Management’s Biolase, Inc. BIOL Stock Holding History

Oracle Investment Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-696
Closed -$725K – 31
2020
Q4 		$725K Hold
696
– – 0.09% 20
2020
Q3 		$478K Hold
696
– – 0.06% 17
2020
Q2 		$1M Sell
696
-1,373
-66% -$1.56M 0.13% 16
2020
Q1 		$1.94M Hold
2,069
– – 0.58% 13
2019
Q4 		$2.86M Hold
2,069
– – 0.54% 15
2019
Q3 		$4.86M Hold
2,069
– – 1.2% 11
2019
Q2 		$7.61M Sell
2,069
-400
-16% -$1.92M 1.64% 10
2019
Q1 		$14.7M Hold
2,469
– – 3.13% 6
2018
Q4 		$6.11M Hold
2,469
– – 1.9% 11
2018
Q3 		$12.8M Hold
2,469
– – 2.8% 6
2018
Q2 		$7.47M Hold
2,469
– – 1.81% 9
2018
Q1 		$12.5M Hold
2,469
– – 3.04% 9
2017
Q4 		$13.2M Buy
2,469
+1,003
+68% +$7.05M 2.61% 9
2017
Q3 		$11M Buy
1,466
+296
+25% +$2.55M 1.81% 9
2017
Q2 		$14.2M Hold
1,170
– – 2.24% 11
2017
Q1 		$19.7M Hold
1,170
– – 3.08% 9
2016
Q4 		$20.5M Buy
1,170
+32
+3% +$633K 3.4% 9
2016
Q3 		$22.6M Buy
1,138
+296
+35% +$5.27M 3.48% 8
2016
Q2 		$12.3M Hold
842
– – 2.87% 9
2016
Q1 		$13.8M Hold
842
– – 3.59% 9
2015
Q4 		$8.86M Buy
842
+4
+0.5% +$43.7K 1.53% 16
2015
Q3 		$9.43M Hold
838
– – 1.93% 17
2015
Q2 		$18.2M Hold
838
– – 2.21% 16
2015
Q1 		$21.2M Hold
838
– – 2.68% 16
2014
Q4 		$27.5M Buy
838
+165
+25% +$5.16M 3.6% 11
2014
Q3 		$20.9M Buy
673
+182
+37% +$5.15M 2.9% 12
2014
Q2 		$13.5M Hold
491
– – 1.64% 18
2014
Q1 		$14.8M Buy
491
+166
+51% +$5.79M 1.69% 17
2013
Q4 		$11.4M Buy
325
+278
+591% +$6.59M 1.57% 19
2013
Q3 		$1.11M Buy
+47
New +$1.51M 0.16% 24

Other funds holding BIOL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DA
DCM Advisors New York $220M AUM 23.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Oracle Investment Management's BIOL Position: Q1 2021 in Review

Oracle Investment Management sold out of Biolase, Inc. (BIOL) in Q1 2021, closing a stake of 696 shares — an estimated $725K sold.

Oracle Investment Management first reported a position in BIOL in Q3 2013 and held it in 30 quarters. The position peaked at $27.5M in Q4 2014. 32 funds tracked by Wall St. Rank hold BIOL as of Q1 2021.

  • Oracle Investment Management reported no remaining Biolase, Inc. position as of Q1 2021 after selling out during the quarter.
  • Oracle Investment Management sold 696 Biolase, Inc. shares in Q1 2021, an estimated $725K.
  • Oracle Investment Management first reported a position in Biolase, Inc. in Q3 2013 and held it in 30 quarters.
  • Oracle Investment Management's Biolase, Inc. position peaked at $27.5M in Q4 2014.
  • 32 funds tracked by Wall St. Rank held Biolase, Inc. as of Q1 2021.

Based on Oracle Investment Management's 13F filing for Q1 2021, filed 17 May 2021.